Patents for C12P 17 - Preparation of heterocyclic carbon compounds with only o, n, s, se, or te as ring hetero atoms (13,366) |
---|
04/01/1992 | CN1016074B Process for preparing esters of 4-(2-hydroxy-3-isopropylamino-propoxy) phenylacetic acid and/or atenolol in stereospecific form |
03/31/1992 | US5101038 Antitumor antibiotic |
03/31/1992 | US5100785 From actinomadura culture, veterinary medicine, treatment of coccidiosis, enteritis, swine dysentery and theileriosis |
03/31/1992 | CA1298222C Process for biological production of amides |
03/29/1992 | WO1992006208A1 Bioconversions catalyzed by the toluene monooxygenase of pseudomonas mendocina kr-1 |
03/29/1992 | CA2069742A1 Bioconversions catalyzed by the toluene monooxygenase of pseudomonas mendocina kr-1 |
03/26/1992 | CA2052097A1 Antiviral agent |
03/25/1992 | EP0477160A1 Process for producing N-substituted-1-deoxynojirimycin |
03/25/1992 | EP0476442A2 L-gulono-gamma-lactone dehydrogenase |
03/25/1992 | CA2051872A1 Directed biosynthesis process for prolyl-immunomycin |
03/25/1992 | CA2050826A1 Microbial preparation of 13.beta.-13-deoxy-22,23-dihydro avermectin-b1a/b1b a glycone |
03/24/1992 | US5099034 Nervous system and cardiovascular disorders |
03/18/1992 | EP0475706A1 Novel squalene synthetase inhibitors |
03/18/1992 | EP0475518A1 28-Hydroxy ivermectin aglycone |
03/17/1992 | US5096924 Antitumor agent; isochromene derivative |
03/17/1992 | US5096923 Novel squalene synthetase inhibitors |
03/17/1992 | US5096922 Sorangicin antibiotics |
03/17/1992 | US5096907 Antibiotic LL-E19085 |
03/17/1992 | US5096884 Glidobactin pf-1 peptide antibiotics |
03/17/1992 | US5096823 Cloning of the bioa, biod, biof, bioc and bioh genes of bacillus spraericus, vectors and transformed cells |
03/17/1992 | CA1297439C Process for producing compounds containing a terminal hydroxyl or epoxy group; and microorganisms suitable therefor |
03/14/1992 | WO1992005269A1 PROCESS FOR PRODUCING β-CARBOLINE DERIVATES |
03/14/1992 | CA2073690A1 Process for the production of beta-carboline derivatives |
03/14/1992 | CA2050739A1 Squalene synthetase inhibitors |
03/13/1992 | CA2050721A1 28-hydroxy ivermectin aglycone |
03/11/1992 | EP0474129A2 1,4-Dihydropyridine derivatives and process for preparing the same |
03/03/1992 | US5093359 Macrolactone antibiotics |
03/03/1992 | US5093338 Lipophilic macrolide useful as an immunosuppressant |
03/03/1992 | US5093250 Process for producing optically active bicyclo[3.3.0]octanedione carboxylic acid esters |
03/03/1992 | US5093248 BU-3862T antitumor antibiotic |
03/03/1992 | US5093247 Phenanthridine derivatives, process for the preparation thereof, and compositions containing them |
03/03/1992 | US5093244 Thymidine or thymine by fermentation of brevibacterium mutant |
03/01/1992 | WO1992004457A1 Antibiotic ge1655 complex and its factors a, b and c |
03/01/1992 | CA2090491A1 Antibiotic ge1655 complex and its factors a, b and c |
02/26/1992 | CN1015596B Preparation of riboflavin, produced by microbial method, in form of spray-dried granules of microgranules |
02/25/1992 | US5091524 Glycosidase inhibitor salbostatin, process for its preparation, and its use |
02/25/1992 | US5091413 Antibiotic agent |
02/25/1992 | US5091389 Lipophilic macrolide useful as an immunosuppressant |
02/25/1992 | US5091311 The production of ksb-1939 macrolides using str eptomyces hygroscopicus |
02/18/1992 | US5089630 Immunoassay, detection of viruses, bacteria |
02/18/1992 | US5089521 Bactericides |
02/18/1992 | US5089487 Hypotensive agents |
02/18/1992 | US5089480 Antiparasitic agents |
02/18/1992 | US5089410 Process for the production of betacyanin pigments |
02/18/1992 | US5089045 Substituted 3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepine-8-ol herbicides |
02/12/1992 | CN1015473B Process for biological production of amides |
02/11/1992 | US5087702 Microbial transformation process for producing an antihypertensive product |
02/11/1992 | CA1295786C Cytotoxic substances from the marine cyanophyte hormothamnion enteromorphoides grunow |
01/28/1992 | US5084392 Process for producing optically active hydroxy lactones |
01/28/1992 | US5084387 Microbiological hydrolysis for the preparation of (exo,exo)-7-oxabicyclo(2.2.1) heptane-2,3, monoacyl ester dimethanol |
01/28/1992 | CA1294910C Process for the enzymatic separation of the optical isomers of racemic oxazolidinonic derivatives |
01/22/1992 | EP0467715A1 Microbial transformation process for antihypertensive products |
01/21/1992 | US5082857 Antibacterial, antitumor |
01/21/1992 | US5082777 Process for the production of 6-hydroxynicotinic acid |
01/20/1992 | CA2047029A1 Microbial transformation process for antihypertensive products |
01/18/1992 | WO1992001781A1 Antibody-mediated cofactor-driven reactions |
01/18/1992 | CA2086755A1 Antibody-mediated cofactor-driven reactions |
01/15/1992 | EP0466115A1 Microbiological oxidation of ethyl groups in heterocycles |
01/15/1992 | EP0466042A2 Microbiological process for the oxidation of methyl groups |
01/15/1992 | CN1057860A Liquid fermentation and refinement of corn gibberellin olefine ketone |
01/14/1992 | US5081264 Bioxanthracene derivatives |
01/14/1992 | US5080899 Method of treating pulmonary inflammation |
01/09/1992 | WO1992000300A1 Antiparasitic agents related to paraherquamide |
01/08/1992 | EP0464905A1 Enzymatic, enantioselective preparation of R-glycidol |
01/08/1992 | EP0464895A2 Process for selectively acylating immunomycin |
01/08/1992 | EP0464656A1 SA3097 compounds, a process for production thereof and use thereof |
01/08/1992 | EP0464582A2 Process for the purification of riboflavin obtained by fermentation |
01/07/1992 | US5079153 Esterification or ester interchange in presence of lipase |
01/07/1992 | US5079152 Antibody combining sites that exhibit stereoselective synthase activity, and methods using the same |
01/07/1992 | US5078999 Method of treating systemic lupus erythematosus |
01/07/1992 | CA2046430A1 Microbiological process for oxidation of methyl groups |
01/02/1992 | EP0463707A1 Production of polyketide antibiotics |
01/02/1992 | EP0463680A1 Method for preparing acetate esters of diols and polyols using corynebacterium oxydans in substantially aqueous media |
01/02/1992 | EP0463677A2 Process for the glycosylation of avermectin aglycones |
12/31/1991 | US5077217 Using enzymes in aqueous solutions |
12/31/1991 | US5077201 Natural blue pigment |
12/31/1991 | CA1293702C Process for obtaining diterpenes of the labdane type, in particular forskolin, from coleus forskohlii |
12/30/1991 | WO1992000373A1 Melanin production by transformed microorganisms |
12/27/1991 | EP0462833A2 Process for the preparation of ascorbic acid-2-phosphate |
12/26/1991 | WO1991019716A1 Antitumor substance be-13793c |
12/26/1991 | CA2045421A1 Process for selectively acylating immunomycin |
12/25/1991 | CN1057194A Prodn. and use of porphyrins |
12/24/1991 | US5075307 Paraherquamide and dihydroparaherquamide as antihelminthic agents |
12/24/1991 | US5075233 Process for the preparation of 2-aryloxypropionic acids |
12/23/1991 | CA2044875A1 Process for the glycosylation of avermectin agylcones |
12/23/1991 | CA2044542A1 Methods for preparing acetate esters of diols and polyols using corynebacterium oxydans in substantially aqueous media |
12/22/1991 | WO1991019799A1 Method for isolating mutant cells |
12/22/1991 | CA2085893A1 Method for isolating mutant cells |
12/17/1991 | US5073567 Milbemycins |
12/17/1991 | US5073549 Antiamnesia, antidementia |
12/15/1991 | WO1991019718A1 Reveromycin a, production thereof, and antitumor drug and fungicide |
12/11/1991 | EP0461043A2 Enantiomer separation by transesterification |
12/11/1991 | EP0460949A2 Enantiomerically selective enzymic acylation of a racemic 3-amino azetidinone |
12/10/1991 | US5071753 Process for the enzymatic preparation of organic esters of ascorbic acid or erythorbic acid |
12/04/1991 | EP0459564A2 Process for reduction of echinocandin type cyclohexapeptide compounds |
12/04/1991 | EP0459449A1 Furano[2,3-F]isoindoles as aldose reductase inhibitors |
12/04/1991 | EP0458970A1 Benzofuran derivative, process for preparing the same, and pharmaceutical comprising the same as active ingredient |
12/03/1991 | US5070022 Lipase from pseudomonas, candida or chromobacterium |
12/03/1991 | CA1292713C Process for producing antibiotic salinomycin |
11/30/1991 | CA2043378A1 Process for reduction of certain cyclohexapeptide compounds |